155 related articles for article (PubMed ID: 30593674)
1. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
[TBL] [Abstract][Full Text] [Related]
3. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
Tse G; Gong M; Li G; Wong SH; Wu WKK; Wong WT; Roever L; Lee APW; Lip GYH; Wong MCS; Liu T;
Br J Clin Pharmacol; 2018 Sep; 84(9):1868-1882. PubMed ID: 29704269
[TBL] [Abstract][Full Text] [Related]
4. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.
Dahal K; Sharma SP; Fung E; Lee J; Moore JH; Unterborn JN; Williams SM
Chest; 2015 Sep; 148(3):701-710. PubMed ID: 25811981
[TBL] [Abstract][Full Text] [Related]
6. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.
Tang HL; Shi WL; Li XG; Zhang T; Zhai SD; Xie HG
Pharmacogenomics J; 2015 Dec; 15(6):496-504. PubMed ID: 25869011
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.
Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG
J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
[TBL] [Abstract][Full Text] [Related]
9. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials.
Wang F; Guo J; Zhang A
J Cardiovasc Pharmacol; 2019 Mar; 73(3):127-135. PubMed ID: 30688796
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.
Wang X; Tang B; Zhou M; Liu L; Feng X; Wang X; Qiu K
Thromb Res; 2022 Feb; 210():42-52. PubMed ID: 34999431
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.
Liao Z; Feng S; Ling P; Zhang G
J Thromb Thrombolysis; 2015 Feb; 39(2):228-34. PubMed ID: 24962733
[TBL] [Abstract][Full Text] [Related]
13. A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Kimmel SE; French B; Kasner SE; Johnson JA; Anderson JL; Gage BF; Rosenberg YD; Eby CS; Madigan RA; McBane RB; Abdel-Rahman SZ; Stevens SM; Yale S; Mohler ER; Fang MC; Shah V; Horenstein RB; Limdi NA; Muldowney JA; Gujral J; Delafontaine P; Desnick RJ; Ortel TL; Billett HH; Pendleton RC; Geller NL; Halperin JL; Goldhaber SZ; Caldwell MD; Califf RM; Ellenberg JH;
N Engl J Med; 2013 Dec; 369(24):2283-93. PubMed ID: 24251361
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.
Li X; Yang J; Wang X; Xu Q; Zhang Y; Yin T
Thromb Res; 2015 Apr; 135(4):621-9. PubMed ID: 25628141
[TBL] [Abstract][Full Text] [Related]
15. Hematology consult: high-sensitivity warfarin genotype.
Schwer C; Lamana S; Dasanu CA
Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
[TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists.
Kheiri B; Abdalla A; Haykal T; Osman M; Ahmed S; Hassan M; Bachuwa G
Am J Cardiol; 2018 Apr; 121(7):879-887. PubMed ID: 29402419
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.
Kangelaris KN; Bent S; Nussbaum RL; Garcia DA; Tice JA
J Gen Intern Med; 2009 May; 24(5):656-64. PubMed ID: 19306050
[TBL] [Abstract][Full Text] [Related]
18. Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.
Franchini M; Mengoli C; Cruciani M; Bonfanti C; Mannucci PM
J Thromb Haemost; 2014 Sep; 12(9):1480-7. PubMed ID: 25040440
[TBL] [Abstract][Full Text] [Related]
19. Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.
Makar-Aušperger K; Krželj K; Lovrić Benčić M; Radačić Aumiler M; Erdeljić Turk V; Božina N
Ther Drug Monit; 2018 Jun; 40(3):362-368. PubMed ID: 29494423
[TBL] [Abstract][Full Text] [Related]
20. Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.
You JH; Tsui KK; Wong RS; Cheng G
Clin Pharmacol Ther; 2009 Nov; 86(5):540-7. PubMed ID: 19571807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
